Novavax, Inc. (NVAX) reported a 3Q25 EPS loss and declining revenue, but beat revenue expectations and reaffirmed its FY25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback